About Abryl
Abryl is a Healthcare company based in Dera Bassi (India) founded in 2016. Manufacturing of sterile injectable products and pre-filled syringes by Abryl. The company has 471 employees. Its Indian entity Abryl Laboratories Private Limited reported revenue of ₹36.91 Cr. Abryl offers products and services including Sterile Injectable Products and Pre-filled Syringes. Its focus areas include Biotechnology, Research and Development, Microbiology and Pharmaceuticals.
Company details
Abryl is established as a state-of-the-art manufacturing facility that produces liquid and freeze-dried sterile injectable products along with pre-filled syringes. Integrity and quality are emphasized to support positive development for the community and business partners. Departments such as production, packing, engineering, quality control, microbiology, and RD are operated, while awards and certificates are noted for recognition. Contact is managed through specified channels, ensuring accessibility for enquiries.
- Headquarters Dera Bassi, India
- Employees 471
- SectorsHealthcare
- Email••••••••
- Website abryl.in
- Legal Name Abryl Laboratories Pvt Ltd
- Date of Incorporation 20 Jan, 2016
- Jurisdiction Chandigarh, India
- Annual Revenue₹36.91 Cr
FY 2025 · +121% YoY
- Net Loss-₹20.18 Cr
FY 2025 · -55% margin
- EBITDA-₹8.05 Cr
FY 2025 · -22% margin
- Employee Count471
Associated legal entities of Abryl
Abryl operates through Abryl Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Abryl Laboratories Private Limited CIN U24232CH2016PTC035904 | Active | 20 Jan 2016 | Chandigarh, Chandigarh | ₹36.9 Cr | 471 | 4 | View details |
Products & Services of Abryl
Abryl offers a comprehensive portfolio of products and services, including Sterile Injectable Products and Pre-filled Syringes.
Liquid and freeze-dried sterile injectables are produced for medical applications.
Pre-filled syringes are manufactured as part of pharmaceutical offerings.
Board of directors of Abryl Laboratories Private Limited (Abryl)
Abryl Laboratories Private Limited is the primary company behind Abryl. The board of Abryl Laboratories Private Limited currently have 2 directors; the longest-serving is Vijay Kumar, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vijay Kumar DIN 06950349 | Director | 20 Jan 2016 | 10 yrs 9 mo | Abryl Laboratories Private Limited |
| Jayant Singla DIN 06995928 | Director | 20 Jan 2016 | 10 yrs 9 mo | Abryl Laboratories Private Limited |
Financials of Abryl
Figures of Abryl Laboratories Private Limited, the primary company behind Abryl, for FY 2025. Revenue was ₹36.91 Cr (+121% year on year). Net loss was -₹20.18 Cr (-55% margin). EBITDA was -₹8.05 Cr (-22% margin). Revenue has grown at a compounded annual rate of -11% over three years and +314% over five years.
- ₹36.91 CrRevenue · FY 2025 · +121% YoY
- -₹20.18 CrNet loss · -55% margin
- -₹8.05 CrEBITDA · -22% margin
- ₹36.31 CrPaid-up capital
- 471Employees (provident fund records)
- -11%Revenue CAGR, 3 years
- +314%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Abryl Laboratories Private Limited are on its company page.
Detailed financial statements for Abryl
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abryl
Abryl was founded in 2016.
Abryl is headquartered in Dera Bassi, India. It is registered at Dera Bassi, Punjab, India.
Abryl has 471 employees.
The primary company behind Abryl, Abryl Laboratories Private Limited, reported revenue of ₹36.91 Cr for FY 2025, up 121% year on year.
Abryl is established as a state-of-the-art manufacturing facility that produces liquid and freeze-dried sterile injectable products along with pre-filled syringes. Integrity and quality are emphasized to support positive development for the community and business partners. Departments such as production, packing, engineering, quality control, microbiology, and RD are operated, while awards and certificates are noted for recognition. Contact is managed through specified channels, ensuring accessibility for enquiries.
Abryl offers Sterile Injectable Products and Pre-filled Syringes.
Abryl operates through Abryl Laboratories Private Limited.
The legal entities of Abryl currently have 4 directors, including Vijay Kumar, Jayant Singla, Arshpreet Kaur Guliani and others.